Product
PRAX-944
Aliases
100 mg PRAX-944, 60 mg PRAX-944, Flexibly dosed 20 mg to 100 mg PRAX-944, Part A: 20 and 40 mg PRAX-944, Part B: 120 mg PRAX-944 (1 other aliases)
2 clinical trials
1 indication
Indication
Essential TremorClinical trial
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Range Finding Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of PRAX-944 in the Treatment of Adults With Essential TremorStatus: Completed, Estimated PCD: 2023-02-09
Clinical trial
A Phase 2 Clinical Trial Evaluating the Efficacy, Safety, Tolerability, and Pharmacokinetics of PRAX-944 in Adults With Essential TremorStatus: Completed, Estimated PCD: 2022-03-24